Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Fulcrum Therapeutics

FULC

FULC Fulcrum Therapeutics NASDAQ
Add to watchlist
4.460
0.000 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    FULC Chart
    See on advanced chart >
    All
    D
    W
    M
    5m
    • Volume 91.76k
    • Turnover 406.31k
    • P/E(TTM) --
    • Turnover % 0.03%
    • P/E(Static) --
    • Market Cap 1.58B
    • P/B 1.47
    • Shares 355.11M
    • 52 Week Range
      2.850
      10.09
    • Day Range
      4.330
      4.480

    About

    Fulcrum Therapeutics, Inc. was incorporated in Delaware on August 18, 2015. They are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial...
    • Highlight
      A clinical biopharmaceutical company focused on improving the lives of patients with hereditary diseases, especially in the field of rare diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/18/2019
    • Established Date
      08/18/2015
    • Full-time Employees
      76
    • Address
      26 Landsdowne Street Cambridge Massachusetts 02139
    • Tel
      1-617-6518851
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App
    All
    QUICK
    Daily
    Weekly
    Monthly
    Minutes
    5 minutes
    15 minutes
    30 minutes
    Ranges
    1 Day
    1 Week
    1 Month
    1 Year
    YTD